Back to Search Start Over

Data from Localized Synchrotron Irradiation of Mouse Skin Induces Persistent Systemic Genotoxic and Immune Responses

Authors :
Olga A. Martin
Carl N. Sprung
Alexandros G. Georgakilas
Vassilis G. Gorgoulis
Ioannis S. Pateras
Georgia Terzoudi
Konstantinos Skordylis
Gianna Potsi
Gerasimos Ch. Pollakis
Vasilis Kotsaris
Andreas Ntargaras
Christopher J. Hall
Andrew W. Stevenson
Alesia Ivashkevich
Nicole M. Haynes
Helen Forrester
Jason S. Palazzolo
Pavel N. Lobachevsky
Jessica Ventura
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

The importance of nontargeted (systemic) effects of ionizing radiation is attracting increasing attention. Exploiting synchrotron radiation generated by the Imaging and Medical Beamline at the Australian Synchrotron, we studied radiation-induced nontargeted effects in C57BL/6 mice. Mice were locally irradiated with a synchrotron X-ray broad beam and a multiplanar microbeam radiotherapy beam. To assess the influence of the beam configurations and variations in peak dose and irradiated area in the response of normal tissues outside the irradiated field at 1 and 4 days after irradiation, we monitored oxidatively induced clustered DNA lesions (OCDL), DNA double-strand breaks (DSB), apoptosis, and the local and systemic immune responses. All radiation settings induced pronounced persistent systemic effects in mice, which resulted from even short exposures of a small irradiated area. OCDLs were elevated in a wide variety of unirradiated normal tissues. In out-of-field duodenum, there was a trend for elevated apoptotic cell death under most irradiation conditions; however, DSBs were elevated only after exposure to lower doses. These genotoxic events were accompanied by changes in plasma concentrations of macrophage-derived cytokine, eotaxin, IL10, TIMP1, VEGF, TGFβ1, and TGFβ2, along with changes in tissues in frequencies of macrophages, neutrophils, and T lymphocytes. Overall, our findings have implications for the planning of therapeutic and diagnostic radiation treatments to reduce the risk of radiation-related adverse systemic effects. Cancer Res; 77(22); 6389–99. ©2017 AACR.

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....01210a2907b7b553e619e666953c19f8